Special Issue "Conotoxins"


A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (30 April 2011)

Special Issue Editors

Guest Editor
Prof. Dr. David Craik
Institute for Molecular Bioscience, University of Queensland, Brisbane QLD 4072, Australia
E-Mail: d.craik@imb.uq.edu.au
Phone: +61 7 3346 2019
Fax: +61 7 3346 2029

Guest Editor
Prof. Dr. David Adams
RMIT Health Innovations Research Institute, RMIT University GPO Box 2476. Melbourne Victoria 3001, Australia
E-Mail: david.adams@rmit.edu.au

Special Issue Information

Dear Colleagues,

This special issue will focus on structural-activity and pharmacological studies of conotoxins. Conotoxins have created much interest in the last two decades because of their exquisite potency and selectivity for a variety of membrane receptors, transporters, and voltage-gated ion channels that has made them exciting targets as drug leads. One conotoxin is currently on the market for neuropathic pain and several others are in preclinical or clinical development. This issue brings together a collection of articles that describes recent developments in the field from leading experts.

Prof. Dr. David Craik
Prof. Dr. David Adams
Guest Editor


  • nicotinic acetylcholine receptors
  • G protein-coupled receptors
  • calcium channels
  • sodium channels
  • potassium channels
  • transporters
  • structure-activity relationships
  • NMR
  • electrophysiology

Published Papers (2 papers)

Mar. Drugs 2013, 11(9), 3537-3553; doi:10.3390/md11093537
Received: 5 August 2013; in revised form: 16 August 2013 / Accepted: 19 August 2013 / Published: 17 September 2013
Show/Hide Abstract | Download PDF Full-text (1080 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2011, 9(10), 1698-1714; doi:10.3390/md9101698
Received: 1 August 2011; in revised form: 29 August 2011 / Accepted: 16 September 2011 / Published: 28 September 2011
Show/Hide Abstract | Download PDF Full-text (3439 KB) | View HTML Full-text | Download XML Full-text

Last update: 27 February 2014

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert